Michael Miley

Title: Michael Miley: Innovator in Vaccine Development

Introduction

Michael Miley is a prominent inventor based in Cary, NC (US), known for his significant contributions to the field of vaccine development. With a total of 2 patents, he has made strides in creating innovative solutions for public health challenges.

Latest Patents

Miley's latest patents include "Methods and compositions for dengue virus vaccines and diagnostics." This invention provides compositions directed to recombinant flavivirus E glycoprotein ectodomain dimers for use in diagnostic and immunotherapeutic methods. Another notable patent is "Disulfide trap MHC class I molecules and uses therefor." This patent discloses a disulfide trap that comprises an antigen peptide covalently attached to an MHC class I heavy chain molecule by a disulfide bond extending between two cysteines. The disulfide trap can be utilized for vaccination, to elicit CD8 T cells, and in multivalent MHC/peptide reagents for the enumeration and tracking of T cells.

Career Highlights

Throughout his career, Michael Miley has worked with esteemed institutions such as Washington University and the University of North Carolina at Chapel Hill. His work has focused on advancing the understanding and treatment of viral infections, particularly through innovative vaccine technologies.

Collaborations

Miley has collaborated with notable colleagues, including Ted H Hansen and Daved Henry Fremont. These partnerships have contributed to the development of his groundbreaking patents and research initiatives.

Conclusion

Michael Miley's work in vaccine development showcases his dedication to improving public health through innovative solutions. His patents reflect a commitment to addressing critical health challenges, particularly in the realm of viral infections.